Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Oct 30;18(6):1268–1279. doi: 10.1016/j.cgh.2019.10.035

Table 1.

Factors contributing to overall disease severity in patients with IBD, use to identify patients at high risk of disease-related complications including surgery, hospitalization and disability.

High-risk Crohn’s disease Low-risk Crohn’s disease
Structural Damage • Large or deep mucosal lesions
• Fistula and/or perianal abscess
• Prior intestinal resections, particularly of segments >40cm
• Presence of strictures
• Aphthous or small superficial ulcers
• Absence of fistulae, abscess or strictures
• No prior intestinal surgeries
Inflammatory burden • Extensive disease (ileal involvement >40cm or pancolitis)
• Elevated C-reactive protein
• Low albumin
• Limited anatomic involvement
• Normal C-reactive protein
• Normal albumin
Impact on quality of life • Presence of stoma
• >10 loose stools/week
• Lack of symptomatic improvement with prior exposure to biologics and/or immunosuppressive agents
• Significant impact of disease on activities of daily living
• Presence of anorectal symptoms (anorectal pain, bowel urgency, incontinence, discharge, tenesmus)
• Anemia
• Daily abdominal pain
• Corticosteroid use within last 1 year
• Modest impact of disease on daily activities
• No prior exposure to biologics and/or immunosuppressive agents
• No prior disease-related hospitalization within the last 1 year
• Absent to mildly active symptoms
Emerging predictors • High number and titer of anti-microbial antibodies
• Antimicrobial genetic peptide signature
-